Regulus Therapeutics
RGLS
#8876
Rank
ยฃ88.67 M
Marketcap
ยฃ1.34
Share price
15.33%
Change (1 day)
-39.64%
Change (1 year)

Regulus Therapeutics (RGLS) - Cash on Hand

Cash on Hand as of December 2024 : ยฃ58.63 Million

According to Regulus Therapeutics's latest financial reports the company has ยฃ58.63 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Regulus Therapeutics - Cash on Hand chart (from 2011 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ60.38 M223.68%
2023-12-31ยฃ18.65 M-42.37%
2022-12-31ยฃ32.36 M-27.64%
2021-12-31ยฃ44.73 M96.14%
2020-12-31ยฃ22.8 M-12.35%
2019-12-31ยฃ26.02 M137.03%
2018-12-31ยฃ10.97 M-75.3%
2017-12-31ยฃ44.44 M-27.94%
2016-12-31ยฃ61.68 M-19.86%
2015-12-31ยฃ76.96 M-24.98%
2014-12-31ยฃ0.10 B48.45%
2013-12-31ยฃ69.11 M13.87%
2012-12-31ยฃ60.69 M147.32%
2011-12-31ยฃ24.54 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
ยฃ3.60 B 6,050.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ6.38 B 10,785.84%๐Ÿ‡ซ๐Ÿ‡ท France
ยฃ1.83 B 3,034.20%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ4.37 B 7,361.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ2.08 B 3,455.83%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ32.43 M-44.68%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ8.40 B 14,230.21%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA